Loading...

Dignitana AB (publ)

DIZTFPNK
Healthcare
Medical - Devices
$0.22
$0.00(0.00%)

Dignitana AB (publ) (DIZTF) Financial Performance & Income Statement Overview

Access detailed quarterly and annual financial reports for Dignitana AB (publ) (DIZTF), covering cash flow, earnings, and balance sheets.

Revenue Growth
4.38%
4.38%
Operating Income Growth
-21.76%
21.76%
Net Income Growth
-10.46%
10.46%
Operating Cash Flow Growth
106.49%
106.49%
Operating Margin
-16.51%
16.51%
Gross Margin
66.25%
66.25%
Net Profit Margin
-17.63%
17.63%
ROE
-222.31%
222.31%
ROIC
-209.00%
209.003%

Dignitana AB (publ) (DIZTF) Income Statement & Financial Overview

View the income breakdown for Dignitana AB (publ) DIZTF across both annual and quarterly reports.

MetricQ1 2025Q4 2024Q3 2024Q2 2024
Revenue$22.01M$23.97M$22.85M$21.84M
Cost of Revenue$7.24M$8.40M$8.00M$6.97M
Gross Profit$14.78M$15.57M$14.85M$14.87M
Gross Profit Ratio$0.67$0.65$0.65$0.68
R&D Expenses$0.00$0.00$0.00$0.00
SG&A Expenses$13.98M$14.06M$12.91M$21.84M
Operating Expenses$16.41M$17.16M$15.58M$25.89M
Total Costs & Expenses$23.64M$25.56M$23.58M$32.87M
Interest Income$0.00$751000.00$93000.00$334000.00
Interest Expense$232000.00$247000.00$910000.00$765000.00
Depreciation & Amortization$2.39M$2.65M$2.86M$4.01M
EBITDA$756000.00$1.82M$2.22M-$6.68M
EBITDA Ratio$0.03$0.08$0.10-$0.31
Operating Income-$1.63M-$1.59M-$730000.00-$10.98M
Operating Income Ratio-$0.07-$0.07-$0.03-$0.50
Other Income/Expenses (Net)-$232000.00$504000.00-$817000.00-$471000.00
Income Before Tax-$1.86M-$1.08M-$1.55M-$11.45M
Income Before Tax Ratio-$0.08-$0.05-$0.07-$0.52
Income Tax Expense$0.00$37000.00$0.00$0.00
Net Income-$1.86M-$1.12M-$1.55M-$11.45M
Net Income Ratio-$0.08-$0.05-$0.07-$0.52
EPS-$0.02-$0.01-$0.02-$0.14
Diluted EPS-$0.02-$0.01-$0.02-$0.14
Weighted Avg Shares Outstanding$80.54M$80.54M$80.54M$79.44M
Weighted Avg Shares Outstanding (Diluted)$80.54M$80.54M$80.54M$79.44M

Over the past four quarters, Dignitana AB (publ) demonstrated steady revenue growth, increasing from $21.84M in Q2 2024 to $22.01M in Q1 2025. Operating income reached -$1.63M in Q1 2025, maintaining a consistent -7% margin over recent quarters. Despite fluctuations in R&D and SG&A expenses, EBITDA remained robust at $756000.00, reflecting operational efficiency. Net income dropped to -$1.86M, with EPS at -$0.02. Disciplined expense management helped sustain profitability, highlighting solid overall financial performance.

Unlock 25+ Years of Financial Data

Get access to extended historical data, advanced metrics, and more with our premium plan

Frequently Asked Questions

;